Incyte (INCY) Other Accumulated Expenses (2017 - 2022)

Incyte (INCY) posted Other Accumulated Expenses of $209.5 million for Q2 2022, up 181.99% on a QoQ basis from $74.3 million in Q1 2022, and up 64.68% year-over-year from $127.2 million in Q2 2021.

Incyte (INCY) Other Accumulated Expenses (2017 - 2022) Analysis & Trends

Incyte's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $209.5 million for Q2 2022.

  • Quarterly Other Accumulated Expenses rose 64.68% year-over-year to $209.5 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $209.5 million (up 64.68% YoY) and the FY2021 annual result came in at $168.4 million, up 379.64% from the prior year.
  • Other Accumulated Expenses was $209.5 million for Q2 2022 at Incyte, up from $74.3 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $209.5 million in Q2 2022 and bottomed at $20.1 million in Q1 2019.
  • A 5-year average of $80.6 million and a median of $72.5 million in 2020 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 379.64% — and 2022, when it plunged 32.52%.
  • Incyte's Other Accumulated Expenses stood at $25.1 million in 2018, then surged by 67.61% to $42.0 million in 2019, then dropped by 16.5% to $35.1 million in 2020, then surged by 379.64% to $168.4 million in 2021, then rose by 24.4% to $209.5 million in 2022.
  • Business Quant data shows INCY's Other Accumulated Expenses at $209.5 million in Q2 2022, $74.3 million in Q1 2022, and $168.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Jun 30, 2022 209.50 Mn
Mar 31, 2022 74.29 Mn
Dec 31, 2021 168.41 Mn
Sep 30, 2021 74.65 Mn
Jun 30, 2021 127.22 Mn
Mar 31, 2021 110.10 Mn
Dec 31, 2020 35.11 Mn
Sep 30, 2020 49.56 Mn
Jun 30, 2020 71.96 Mn
Mar 31, 2020 73.05 Mn
Dec 31, 2019 42.05 Mn
Jun 30, 2019 47.40 Mn
Mar 31, 2019 20.08 Mn
Dec 31, 2018 25.09 Mn
Dec 31, 2017 22.81 Mn